4,6-二氨基-2-溴烟腈 | 42530-03-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4,6-二氨基-2-溴烟腈
• 英文名称: 2-bromo-3-cyano-4,6-diamino-pyridine
• 英文别名: 2-Brom-4,6-diaminopyridin-3-carbonitril；2-bromo-4,6-diaminonicotinonitrile；4,6-diamino-2-bromonicotinonitrile；2-Brom-3-cyan-4,6-diaminopyridin；6-bromo-2,4-diamino-5-cyanopyridine；4,6-diamino-2-bromopyridine-3-carbonitrile
• CAS: 42530-03-0
• 化学式: C₆H₅BrN₄
• mdl: MFCD06661848
• 分子量: 213.037
• InChiKey: NKXPRYBNUGINBZ-UHFFFAOYSA-N

物化性质

• 沸点：
  503.5±50.0 °C(Predicted)
• 密度：
  1.88±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  88.7
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  2-8°C

反应信息

• 作为反应物：
  描述：

  4,6-二氨基-2-溴烟腈 在 sodium hydride 作用下， 以 1,4-二氧六环 为溶剂， 反应 0.67h， 以79%的产率得到4,6-diamino-2-phenoxy-nicotinonitrile
  参考文献：
  名称：

  Inhibitors of c-Jun N-terminal kinases

  摘要：

  本发明涉及作为c-jun N-末端激酶1、2或3（JNK1、JNK2或JNK3）抑制剂的化合物，包含这些化合物的组合物以及这些化合物在预防或治疗由JNK1、JNK2和JNK3激活调控的疾病中的用途。

  公开号：

  US20060173050A1
• 作为产物：
  描述：

  2-氨基-1-丙烯基-1,1,3-三甲腈 在 氢溴酸 、 溶剂黄146 作用下， 以79%的产率得到4,6-二氨基-2-溴烟腈
  参考文献：
  名称：

  Synthesis of N-substituted Pyrido[4,3-d]pyrimidines for the Large-Scale Production of Self-Assembled Rosettes and Nanotubes

  摘要：

  N-substituted pyrido[4,3-d]pyrimidines are heterocycles which exhibit the asymmetric hydrogen bonding codes of both guanine and cytosine at 60 degrees angles to each other, such that the molecules self-organize unambiguously into a cyclic hexamer, assembled via 18 intermolecular hydrogen bonds. The synthesis is straightforward and can be concluded in six steps from the commercially available malononitrile dimer. X-ray crystallographic analysis of the supermacrocyclic structure shows an undulating disk with a ca. 10.5 angstrom cavity, the centers of which do not overlap sufficiently to describe a channel in the solid state. However, AFM, SEM, and TEM imaging in solution reveals the formation of 1D nanostructures in agreement with their self-assembly into rosette supermacrocycles, which then stack linearly to form rosette nanotubes.

  DOI：

  10.1021/jo4019792

文献信息

• Bicyclic compounds capable of inhibiting tyrosine kinases of the
  申请人：Warner-Lambert Company

  公开号：US05654307A1

  公开（公告）日：1997-08-05

  Novel 4-substituted amino pyrido pyrimidine and 4-substituted amino pyrido pyrimidine inhibitors of epidermal growth factor receptor family of tyrosine kinase are described, as well as pharmaceutical compositions of the same, which are useful in treating proliferative diseases such as cancer, synovial pannus invasion in arthritis, psoriasis, vascular restenosis and angiogenesis and additionally useful in the treatment of pancreatitis and kidney disease as well as a contraceptive agent.

  描述了新型4-取代氨基吡啶嘧啶和4-取代氨基吡啶嘧啶抑制剂对表皮生长因子受体家族的酪氨酸激酶的作用，以及相应的药物组合物，这些药物在治疗癌症、关节炎中的滑膜侵袭、牛皮癣、血管再狭窄和血管生成方面非常有用，此外还可用于治疗胰腺炎和肾病，以及作为避孕药剂。
• 6-Aryl pyrido\x9b2,3-d! pyrimidines and naphthyridines for inhibiting
  申请人：——

  公开号：US05733913A1

  公开（公告）日：1998-03-31

  6-Aryl pyrido\x9b2,3-d!pyrimidines and naphthyridines are inhibitors of protein tyrosine kinase, and are thus useful in treating cellular proliferation mediated thereby. The compounds are especially useful in treating atherosclerosis, restenosis, psoriasis, as well as bacterial infections.

  6-芳基吡啶并[2,3-d]嘧啶和萘嘧啶是蛋白酪氨酸激酶的抑制剂，因此在治疗由此介导的细胞增殖方面非常有用。这些化合物在治疗动脉粥样硬化、再狭窄、牛皮癣以及细菌感染方面特别有用。
• Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle
  申请人：Warner-Lambert Company

  公开号：US06150359A1

  公开（公告）日：2000-11-21

  This invention relates to the inhibition of protein tyrosine kinase (PTK) and cell cycle kinase mediated cellular proliferation. More specifically, this invention relates to naphthyridinones and their use in inhibiting cellular proliferation and PTK or cell cycle kinase enzymatic activity.

  这项发明涉及抑制蛋白酪氨酸激酶（PTK）和细胞周期激酶介导的细胞增殖。更具体地说，这项发明涉及萘啶酮及其在抑制细胞增殖和PTK或细胞周期激酶酶活性中的用途。
• Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
  申请人：——

  公开号：US20010027197A1

  公开（公告）日：2001-10-04

  Described are compounds and a method of inhibiting epidermal growth factor receptor tyrosine kinase by treating, with an effective inhibiting amount, a mammal, in need thereof, a compound of Formula II: 1 where: one of A or E is nitrogen, with remaining atoms carbon; X=O, S, NH or NR 7 , such that R 7 =lower alkyl (1-4 carbon atoms), OH, NH 2 , lower alkoxy (1-4 carbon atoms) or lower monoalkylamino (1-4 carbon atoms). Other terms are described in the specification.

  本文描述了一种化合物和一种方法，通过使用有效的抑制量，用公式II：1的化合物来抑制表皮生长因子受体酪氨酸激酶，治疗需要的哺乳动物，其中：A或E中的一个是氮，其余原子为碳；X=O、S、NH或NR7，其中R7=低碳基（1-4个碳原子）、羟基、NH2、低碳基氧（1-4个碳原子）或低碳单烷基氨基（1-4个碳原子）。其他术语在说明书中描述。
• Sulphatoethylene (sulphonyl or sulphonylamino) phenyleneazo dyestuffs
  申请人：Ciba-Geigy Corporation

  公开号：US03998805A1

  公开（公告）日：1976-12-21

  Dyestuffs of the formula ##STR1## wherein B is the radical of a coupling component of the dispersion series, which is derived from an N-alkylated aniline or aminonaphthalene, and which contains in the o-position with respect to the azo bridge a free or acylated primary or secondary amino group, and which is free from water-solubilizing groups, R is a hydrogen atom, a cycloalkyl group or an optionally substituted alkyl group. The new dyestuffs give yellow, red or orange shades on polyester fibers and can be applied from aqueous baths without addition of dispersing agents.

  公式为##STR1##的染料，其中B是分散系列偶联组分的基团，该偶联组分源自于N-烷基化苯胺或氨基萘，且在与偶氮桥相对的o-位置含有自由或酰化的一级或二级氨基团，且不含有水溶性基团，R是氢原子、环烷基或可选取代的烷基。这些新染料在涤纶纤维上呈现黄色、红色或橙色，并且可以在无需添加分散剂的水性浴中应用。